Gastric Cancer
📧 Sign up to get email alerts when something new happens for Gastric Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric Cancer [Phase 1]
Phase 1 clinical trial update evaluating CM082 in combination with paclitaxel as second-line therapy for advanced gastric cancer.
-
CLINICAL_TRIALS trial_result · 2019-02-21Clinical Trial Update: Extensive Intraoperative Peritoneal Lavage After Curative Gastrectomy for Locally Advanced Gastric Cancer (SEIPLUS) [NA]
SEIPLUS investigates extensive intraoperative peritoneal lavage after curative gastrectomy for locally advanced gastric cancer. The trial st…
-
CLINICAL_TRIALS research · 2019-02-20Clinical Trial Update: Intra-arterial Infusion Chemotherapy Combined With Sodium Bicarbonate for Unresectable Gastric Cancer [EARLY_Phase 1]
This clinical trial update describes an early-phase study evaluating intra-arterial infusion chemotherapy combined with sodium bicarbonate f…
-
CLINICAL_TRIALS trial_result · 2019-02-20Clinical Trial Update: Study On Safety Of Laparoscopic Total Gastrectomy For Clinical Stage I Gastric Cancer [NA]
A completed clinical trial evaluating the safety of laparoscopic total gastrectomy for clinical stage I gastric cancer.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma [Phase 2]
This is a Phase 2 clinical trial update assessing chemotherapy for advanced esophagogastric adenocarcinoma.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-02-12Clinical Trial Update: FLO +/- Pazopanib as First-line Treatment in Advanced Gastric Cancer [Phase 2]
A Phase 2 trial evaluating FLO (5-fluorouracil, leucovorin, oxaliplatin) with or without Pazopanib as first-line therapy for advanced gastri…
-
CLINICAL_TRIALS research · 2019-02-12Clinical Trial Update: Non-exposure Simple Suturing EFTR (NESS-EFTR) With Laparoscopic Sentinel Lymph Node Navigation for EGC (Senorita3-phase 2) [Phase 2]
Phase 2 clinical trial update on Non-exposure Simple Suturing EFTR with Laparoscopic Sentinel Lymph Node Navigation (Senorita3-phase 2) for …
-
CLINICAL_TRIALS research · 2019-02-11Clinical Trial Update: Magnifying Endoscopy With Narrow Band Imaging Versus Endoscopic Ultrasonography for Prediction of Tumor Invasion Depth in Early Gastric Cancer: A Prospective Comparative Study
A prospective comparative study evaluating magnifying endoscopy with narrow-band imaging versus endoscopic ultrasonography to predict tumor …
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Clinical Trials for the Prevention of Gallstone Formation After Gastrectomy in Patient With Gastric Cancer [Phase 3]
Phase 3 trial evaluating prevention of gallstone formation after gastrectomy in patients with gastric cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2019-02-08Clinical Trial Update: Celecoxib/Oxaliplatin/Capecitabine for Gastric/Gastroesophageal Junction Carcinoma [Phase 2]
A Phase 2 trial of Celecoxib in combination with Oxaliplatin and Capecitabine for gastric cancer and gastroesophageal junction cancer has be…
-
CLINICAL_TRIALS trial_result · 2019-02-01Clinical Trial Update: Flexible Endoscopy Biopsies for Submucous Tumors With a New Drill Instrument [NA]
This clinical trial update reports on a new drill instrument used for flexible endoscopy biopsies of submucosal gastric tumors. The study st…
-
CLINICAL_TRIALS trial_result · 2019-01-31Clinical Trial Update: Nutritional Status and Nutrient Supply in Hospitalised Surgical Patients
This clinical trial update notes the completion of a study assessing nutritional status and nutrient supply in hospitalized surgical patient…
-
CLINICAL_TRIALS trial_result · 2019-01-29Clinical Trial Update: Trial of 4-regimen (SP, FL/Tax, FL/Doc, FOLFOX) in Patients With Recurrent or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating four regimens (SP, FL/Tax, FL/Doc, and FOLFOX) in recurrent or metastatic gastric cancer has completed.
-
CLINICAL_TRIALS research · 2019-01-29Clinical Trial Update: Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients [Phase 4]
A Phase 4 clinical trial in Korean patients investigates whether UGT1A1 genetic polymorphisms influence irinotecan toxicity in colorectal an…
-
CLINICAL_TRIALS trial_result · 2019-01-25Clinical Trial Update: Bioinformation Therapy for Gastric Cancer [Phase 2, Phase 3]
The document notes the completion of Phase 2 and Phase 3 trials evaluating Bioinformation Therapy for advanced gastric cancer.
-
CLINICAL_TRIALS research · 2019-01-24Clinical Trial Update: Clinical Study of Weifuchun Treatment on Precancerous Lesions of Gastric Cancer [EARLY_Phase 1]
An early-phase 1 clinical study is being conducted to assess Weifuchun for precancerous gastric lesions in patients with chronic atrophic ga…
-
CLINICAL_TRIALS trial_result · 2019-01-23Clinical Trial Update: S-1+Oxaliplatin vs.S-1+Cisplatin First-line Treatment of Advanced or Recurrent Non-intestinal Type Gastric Adenocarcinoma Patients [Phase 3]
A Phase 3 trial comparing S-1 plus oxaliplatin versus S-1 plus cisplatin as first-line therapy for advanced or recurrent non-intestinal type…
-
CLINICAL_TRIALS trial_result · 2019-01-22Clinical Trial Update: An Effect of an Individualized Physical Activity Intervention for Gastric Cancer Patient Undergoing Minimally Invasive Gastrectomy: a Phase III, Prospective Randomized Controlled Trial [Phase 3]
A Phase III randomized controlled trial update evaluating an individualized physical activity program for patients with gastric cancer under…
-
FDA approval · 2018-12-14FDA Approved: HERZUMA — Original Application (Cephalon, Inc.)
FDA approved Herzuma (trastuzumab) through an original Biologics License Application, establishing it as a biosimilar to trastuzumab for ind…
-
FDA approval · 2018-12-06FDA Approved: TYKERB — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Tykerb (lapatinib) from Novartis Pharmaceuticals Corporation, approving an additional indication…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Efficacy and Safety Study of Olaparib in Combination With Paclitaxel to Treat Advanced Gastric Cancer. [Phase 3]
Phase 3 trial assessing olaparib in combination with paclitaxel for advanced gastric cancer has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating pembrolizumab with a monoclonal antibody therapy in advanced cancers; study TERMINATED with results posted in 201…
-
CLINICAL_TRIALS trial_result · 2018-11-02Clinical Trial Update: Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer [Phase 2]
Phase 2 clinical trial update evaluating matuzumab in combination with epirubicin, cisplatin, and capecitabine (ECX) for esophago-gastric ca…
-
CLINICAL_TRIALS trial_result · 2018-11-01Clinical Trial Update: Avastin and Taxotere for Esophagogastric Cancer [Phase 2]
Phase 2 trial update evaluating Avastin and Taxotere for esophagogastric cancers has been completed.
-
CLINICAL_TRIALS trial_result · 2018-10-31Clinical Trial Update: A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2]
Phase 2 trial evaluating intraperitoneal and intravenous paclitaxel with apatinib and S-1 conversion therapy for gastric cancer with positiv…